Skip to main content
Clinical Trials/CTRI/2021/04/033122
CTRI/2021/04/033122
Not yet recruiting
未知

A prospective study to evaluate the efficacy and adverse effects of alpha blockers in the management of benign prostatic hyperplasia

DR I C VIGNESH RAJA0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: N401- Benign prostatic hyperplasia withlower urinary tract symptoms
Sponsor
DR I C VIGNESH RAJA
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
DR I C VIGNESH RAJA

Eligibility Criteria

Inclusion Criteria

  • Benign prostatic hyperplasia with international prostatic symptom score above 7
  • Patient on silodosin
  • Patient on tamsulosin
  • willing to give informed consent

Exclusion Criteria

  • Prostate carcinoma
  • Patients with concomitant HIV, HBV or HCV
  • Renal failure
  • Liver disease
  • Patient planned for cataract surgery.
  • Psychiatry patients

Outcomes

Primary Outcomes

Not specified

Similar Trials